All In Biotech

Drug Trial Radar · NCT01087671

Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops

Ocular Signs and Symptoms in Patients With Ocular Hypertension or Open-angle Glaucoma Switched From Preserved Latanoprost 0.005% Eye Drops to Preservative Free Tafluprost Eye Drops

Last checked: Nov 20, 2026Latest source record: May 31, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

185

Actual

Start

Apr 2010

Primary completion

Oct 2010

Study completion Oct 2010

Sponsor

Lead sponsor
Santen OyIndustry
Sponsor type
Industry
First posted
Mar 16, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate if changes in ocular signs and symptoms occur in patients with ocular hypertension or glaucoma when they switch from latanoprost 0.005% (Xalatan) to preservative free Tafluprost eye drops.

Conditions

  • Ocular Hypertension
  • Open-Angle Glaucoma

Interventions

  • tafluprostDrug

    prostaglandin analogue

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assessment of changes in ocular symptoms and signsTime frame: From Screening (Visit 1) to12 weeks.

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.